Accelerator Lead News Today

A global slowdown in startup investing may mean that startups looking to raise growth-stage capital will meet stiffer headwinds. On the other hand, more money looks poised to flow to early-stage deals as the big venture capital firms like Tiger Global move to pick younger companies potentially firing up valuations at earlier stages. So the problem may not be a dearth of capital. But with so much money expected to shift from late-stage companies to younger firms, will Africa’s early-stage inves...

The ACT Accelerator partnership welcomes commitment of 870 million vaccine doses and calls for more investment in all tools to end the pandemic The ACT Accelerator partnership welcomes commitment of 870 million vaccine doses and calls for more investment in all tools to end the pandemic T otal funding committed to the ACT-Accelerator partnership remains US$ 15.1 billion with a gap of over US$16 billion. At the close of this year’s G7 Leaders’ summit, the Prime Minister of the United Kingdom...

At the close of this year’s G7 Leaders’ summit, the Prime Minister of the United Kingdom of Great Britain and Northern Ireland announced a donation of an additional 870 million vaccine doses from attendees, with the majority to be delivered through COVAX, the vaccines pillar of the Access to COVID 19 Tools Accelerator, within the next year.

English News and Press Release on World about Health and Epidemic; published on 13 Jun 2021 by WHO

New strategy may change the course of evolving COVID-19 pandemic Launched in April 2020 by the World Health Organization (WHO), European Commission, France and The Bill & Melinda Gates Foundation, the ACT Accelerator is a partnership of leading public health agencies with equity at its heart. In under a year, the ACT Accelerator has driven real progress to accelerate the end of the COVID-19 pandemic. It has accelerated the development of COVID-19 tests, treatments, vaccines and health systems a...

ACT-Accelerator releases prioritised strategy and budget for 2021 to change the course of the evolving COVID-19 pandemic ACT-Accelerator releases prioritised strategy and budget for 2021 to change the course of the evolving COVID-19 pandemic 12 March 2021 Reading time: Launched in April 2020 by the World Health Organization (WHO), European Commission, France and The Bill & Melinda Gates Foundation, the ACT Accelerator is a partnership of leading public health agencies with equity at...

Key breakthroughs in the race to rid the world of the virus – and the difficulties that could lie ahead

Azithromycin is an antibiotic which is known to treat inflammation in patients It had been speculated it may help people suffering with severe Covid-19  Hospitalised patients suffer inflammation as their immune system attacks itself But RECOVERY trial has now found it has no impact on chance of death, hospital stay or likelihood of needing to be put on a ventilator